Literature DB >> 16709582

Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype.

G Giovannoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16709582      PMCID： PMC2077737          DOI： 10.1136/jnnp.2006.090944

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  17 in total

1.  Neuromyelitis optica: what it is and what it might be.

Authors:  Brian G Weinshenker
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

2.  Western vs optic-spinal MS: two diseases, one treatment?

Authors:  Brian Weinshenker
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

3.  An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion.

Authors:  M Nakamura; M Endo; K Murakami; H Konno; K Fujihara; Y Itoyama
Journal:  Mult Scler       Date:  2005-12       Impact factor: 6.312

4.  Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.

Authors:  T Misu; K Fujihara; I Nakashima; S Sato; Y Itoyama
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

5.  Plasma exchange for severe attacks of CNS demyelination: predictors of response.

Authors:  M Keegan; A A Pineda; R L McClelland; C H Darby; M Rodriguez; B G Weinshenker
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

6.  Aquaporin expression in normal human kidney and in renal disease.

Authors:  Jennifer J Bedford; John P Leader; Robert J Walker
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

7.  Chronic relapsing inflammatory optic neuropathy (CRION).

Authors:  D Kidd; B Burton; G T Plant; E M Graham
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

8.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

9.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Raul N Mandler; Dorian McGavern; Wolfgang Bruck; Gerald Gleich; Richard M Ransohoff; Corinna Trebst; Brian Weinshenker; Dean Wingerchuk; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2002-07       Impact factor: 13.501

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307
View more
  6 in total

1.  Neuromyelitis and more: the unfolding spectrum of aquaporin 4-related neurological diseases.

Authors:  Orhan Aktas; Hans-Peter Hartung
Journal:  J Neurol       Date:  2009-11       Impact factor: 4.849

Review 2.  [Inflammatory diseases of the spinal column and the myelon].

Authors:  F J Ahlhelm; J M Lieb; S Ulmer; T Sprenger; C Stippich; J Kelm
Journal:  Radiologe       Date:  2011-09       Impact factor: 0.635

3.  A mighty mouse: building a better model of multiple sclerosis.

Authors:  Richard M Ransohoff
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 4.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

5.  Aquaporin 4 regulation during acute and long-term experimental Herpes simplex virus encephalitis.

Authors:  F J Martinez Torres; D Völcker; N Dörner; Th Lenhard; S Nielsen; J Haas; K Kiening; U Meyding-Lamadé
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

6.  Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Authors:  Friedemann Paul; Sven Jarius; Orhan Aktas; Martin Bluthner; Oliver Bauer; Heribert Appelhans; Diego Franciotta; Roberto Bergamaschi; Edward Littleton; Jacqueline Palace; Hans-Peter Seelig; Reinhard Hohlfeld; Angela Vincent; Frauke Zipp
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.